Friulchem spa

Investor Relations

FRIULCHEM (AIM) – “WITH PHARMABBIE ANOTHER STEP FOR INTERNATIONAL GROWTH IN THE VETERINARY SECTOR”

Friulchem ​​purchased 13% of the capital of Pharmabbie last March, an American company specialized in the development of veterinary drugs to be distributed in the US market through FC-CUBE technology.

Market Insight Pharmabbie

Scroll to Top